Cite
HARVARD Citation
Kronbichler, A. et al. (n.d.). FC062: Baseline Soluble Immune Checkpoints Predict Relapse Risk in PR3-Anca Vasculitis Following Rituximab Induction Therapy. Nephrology dialysis transplantation. p. . [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Kronbichler, A. et al. (n.d.). FC062: Baseline Soluble Immune Checkpoints Predict Relapse Risk in PR3-Anca Vasculitis Following Rituximab Induction Therapy. Nephrology dialysis transplantation. p. . [Online].